Related references
Note: Only part of the references are listed.Generation of a conditional disruption of the Tsc2 gene
Omar Hernandez et al.
GENESIS (2007)
Akt induces β-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity
S Fatrai et al.
DIABETES (2006)
Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis
I Ruvinsky et al.
GENES & DEVELOPMENT (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Insulin receptor substrate-2 proteasomal degradation mediated by a mammalian target of rapamycin (mTOR)-induced negative feedback down-regulates protein kinase B-mediated signaling pathway in β-cells
I Briaud et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
SH Um et al.
NATURE (2004)
mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells
M Murakami et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
DD Sarbassov et al.
CURRENT BIOLOGY (2004)
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
E Jacinto et al.
NATURE CELL BIOLOGY (2004)
Decreasing IRS-2 expression in pancreatic β-cells (INS-1) promotes apoptosis, which can be compensated for by introduction of IRS-4 expression
MK Lingohr et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2003)
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
K Inoki et al.
GENES & DEVELOPMENT (2003)
Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins
Y Zhang et al.
NATURE CELL BIOLOGY (2003)
Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2
A Garami et al.
MOLECULAR CELL (2003)
Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes
AM Hennige et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Defective insulin secretion in pancreatic β cells lacking type 1 IGF receptor
SH Xuan et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
IRS proteins and the common path to diabetes
MF White
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
K Inoki et al.
NATURE CELL BIOLOGY (2002)
MTOR interacts with Raptor to form a nutrient-sensitive complex that signals to the cell growth machinery
DH Kim et al.
CELL (2002)
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-Kinase/Akt pathway
BD Manning et al.
MOLECULAR CELL (2002)
Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-α or EGF, augments pancreatic β-cell proliferation
MK Lingohr et al.
DIABETES (2002)
Islet β cell expression of constitutively active Akt1/PKBα induces striking hypertrophy, hyperplasia, and hyperinsulinemia
E Bernal-Mizrachi et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Protein kinase Cζ activation mediates glucagon-like peptide-1-induced pancreatic β-cell proliferation
J Buteau et al.
DIABETES (2001)
Clinical review 135 -: The importance of β-cell failure in the development and progression of type 2 diabetes
SE Kahn
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Life and death of the pancreatic β cells
S Bonner-Weir
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2000)
Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2
Y Kido et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
